The Prostate Cancer Prevention Trial risk calculator and the relationship between prostate‐specific antigen and biopsy outcome

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|119|16|3007-3011

ISSN： 0008-543x

Source： CANCER, Vol.119, Iss.16, 2013-08, pp. : 3007-3011

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The relationship between prostate‐specific antigen and TNM classification or Gleason score in prostate cancer patients with low prostate‐specific antigen levels

By  

THE PROSTATE, Vol. 75, Iss. 10, 2015-07 ,pp. : 1034-1042

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Use of the Finasteride-Adjusted Prostate Cancer Prevention Trial Prostate Cancer Risk Calculator in a Mexican Referral Population: A Validation Study

By  

Urologia Internationalis, Vol. 89, Iss. 1, 2012-05 ,pp. : 9-16

Karger

Access to resources Recommend Favorite

Multiparametric magnetic resonance imaging outperforms the Prostate Cancer Prevention Trial risk calculator in predicting clinically significant prostate cancer

By  

CANCER, Vol. 120, Iss. 18, 2014-09 ,pp. : 2876-2882

John Wiley & Sons Inc

Access to resources Recommend Favorite

Relationship between Dietary Factors and Prostate-Specific Antigen in Healthy Men

By  

Urologia Internationalis, Vol. 89, Iss. 3, 2012-07 ,pp. : 270-274

Karger

Access to resources Recommend Favorite

Comparison of 6- and 12-Core Prostate Biopsy in Taiwanese Men: Impact of Total Prostate-Specific Antigen, Prostate-Specific Antigen Density and Prostate Volume on Prostate Cancer Detection

By  

Urologia Internationalis, Vol. 82, Iss. 3, 2009-05 ,pp. : 270-275

Karger

Access to resources Recommend Favorite